RXI Pharmaceuticals Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
RXI Pharmaceuticals Corp
TickerSLS
CIK #0001390478
CUSIP81642T100
SectorLife Sciences - Pharmaceutical Preparations
Address60 Prescott Street, Worcester, MA 01605
Source [EDGAR]
CIK Filing 2011 - 2025
[0001390478] 10-K
[0001390478] 10-Q
[0001390478] 3
[0001390478] 4
[0001390478] 5
[0001390478] 8-K
[0001390478] D
[0001390478] SC 13D
[0001390478] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Sellas Life Sciences Group Inc [2025-07-29] 0.0
Anson Funds Management LP Sellas Life Sciences Group Inc [2025-05-15] 0.0
Highbridge Capital Management LLC Sellas Life Sciences Group Inc [2024-02-07] 6.5
Packer Paul Sellas Life Sciences Group Inc [2020-09-21] 5.3
Hirschman Orin Sellas Life Sciences Group Inc [2020-08-25] 9.9
CVI Investments Inc Sellas Life Sciences Group Inc [2020-01-17] 0.9
Anson Funds Management LP Sellas Life Sciences Group Inc [2019-06-24] 9.7
Renaissance Technologies LLC Sellas Life Sciences Group Inc [2019-02-12] 5.55
Altium Capital Management LP Sellas Life Sciences Group Inc [2018-07-23] 9.81
683 Capital Management LLC Sellas Life Sciences Group Inc [2018-07-23] 0.8
Empery Asset Management LP Sellas Life Sciences Group Inc [2018-07-18] 0.99
Equilibria Capital Management Ltd Sellas Life Sciences Group Inc [2018-01-08] 50.1
Stergiou Angelos M Sellas Life Sciences Group Inc [2018-01-08] 11.0
CVI Investments Inc Galena Biopharma Inc [2017-02-17] 0.3
Ayrton Capital LLC Galena Biopharma Inc [2017-02-17] 4.7
Sabby Management LLC Galena Biopharma Inc [2017-02-15] 4.72
BlackRock Inc Galena Biopharma Inc [2017-01-30] 5.7
CVI Investments Inc Galena Biopharma Inc [2016-07-15] 6.7
Sabby Management LLC Galena Biopharma Inc [2016-07-12] 4.77
BlackRock Inc Galena Biopharma Inc [2014-01-29] 6.3
Sabby Management LLC Galena Biopharma Inc [2013-01-02] 4.1
Form 3/4/5 Filer 2011 - 2025
van Nostrand Robert L
SELLAS Life Sciences Group, Inc.
Wasman Jane
Kalin Katherine Bach
Stergiou Angelos M.
Scheinberg David A
Varian John
Cicic Dragan
Burns John Thomas
Wood Barbara A
Francomano Robert
Sarlis Nicholas J.
Ghiglieri Stephen F
Varibobi Financial Holdings Ltd
Castilian Ltd.
Tafur Daniel
EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund`
Lopez Fabio
EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fun
Equilibria Capital Management Ltd
EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund
EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund
Mack Gene
Torre Gregory M
Krylov Aleksey N.
Einhorn Irving M.
Ashton William
Chin Richard
Nisi Rudolph
Gray Mary Ann
Hillsberg Sanford
Galliker Stephen S
Gerber Sander
Hudson Bay Capital Management LP
Knapp Thomas J
Nejadnik Bijan
Schwartz Mark W
Dunlap Ryan
Kriegsman Steven A
Kivinski Margaret
Hamilton Brian L
Ahn Mark J
Phio Pharmaceuticals Corp.
Mazanet Rosemary
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2025-06-30] SOLE 0 6,528,778
BlackRock, Inc. [2025-06-30] SOLE 4,518,310 4,590,273
Marshall Wace LLP [2025-06-30] OTR 0 2,715,489
Caligan Partners LP [2025-06-30] SOLE 2,300,000 2,300,000
Geode Capital Management LLC [2025-06-30] DFND 2,200,428 2,200,428
Susquehanna International Group LLP [2025-06-30] OTR 1,489,672 1,746,772
Millennium Management LLC [2025-06-30] SOLE 1,127,225 1,127,225
State Street Corp [2025-06-30] DFND 982,672 1,112,705
Morgan Stanley [2025-06-30] DFND 545,698 1,084,478
Nuveen, LLC [2025-06-30] DFND 971,329 971,329
Northern Trust Corp [2025-06-30] DFND 683,893 683,893
Citadel Advisors LLC [2025-06-30] DFND 577,893 577,893
Goldman Sachs Group Inc [2025-06-30] DFND 465,506 465,506
GSA Capital Partners LLP [2025-06-30] SOLE 426,584 426,584
Diadema Partners LP [2025-06-30] SOLE 400,000 400,000
UBS Group AG [2025-06-30] DFND 309,687 309,687
Charles Schwab Investment Management Inc [2025-06-30] SOLE 294,106 294,106
Anson Funds Management LP [2025-06-30] DFND 275,000 275,000
Jane Street Group LLC [2025-06-30] DFND 46,682 255,482
Opus Capital Group LLC [2025-06-30] SOLE 240,000 240,000
Bank of New York Mellon Corp [2025-06-30] DFND 197,689 201,460
Two Sigma Investments LP [2025-06-30] SOLE 197,642 197,642
Barclays PLC [2025-06-30] SOLE 172,803 172,803
RhumbLine Advisers [2025-06-30] SOLE 39,430 135,789
Vanguard Group Inc [2025-06-30] DFND 0 126,021
XTX Topco Ltd [2025-06-30] DFND 76,900 76,900
LPL Financial LLC [2025-06-30] SOLE 0 67,560
JPMorgan Chase & Co [2025-06-30] DFND 16,792 61,892
MetLife Investment Management LLC [2025-06-30] DFND 58,844 58,844
Atom Investors LP [2025-06-30] SOLE 54,624 54,624
Prev | Page 3 | Next
Terms | Privacy | Guide
tony@aum13f.com